Researchers Examine Drug Potential for Preventing Skin Inflammation and Hair Loss

Introduction to the Study

Recent research published in *Scientific Reports* investigates whether a specific drug could help prevent skin inflammation and hair loss in laboratory mice. Hair loss and the graying of hair are common aspects of aging, yet effective treatments remain limited. To develop new therapies, scientists require a deeper understanding of the biological mechanisms behind hair loss.

Study Overview

A collaborative effort between American and Chinese researchers focused on the effects of a drug on genetically modified mice lacking the Apolipoprotein E gene. These mice are prone to high blood cholesterol levels, making them suitable for cardiovascular disease studies, while also experiencing skin problems that lead to hair loss and inflammation.

Mice Observations

The researchers placed the mice on a high-fat and high-cholesterol diet for six months. As a result, the mice experienced a significant loss of hair—approximately 75% on their backs—along with visible skin changes, including increased whiteness due to fat accumulation, heightened inflammation, and numerous skin lesions.

Drug Intervention and Effects

The outer layer of skin cells contains various fats that maintain its waterproof nature and barrier function. Previous studies indicated that glycosphingolipids, a specific type of fat, may contribute to skin issues. The researchers administered two drugs, BPD and D-PDMP, which inhibit the synthesis of glycosphingolipids.

They measured the effectiveness of these inhibitors in preventing hair loss and skin inflammation in the mice. Results showed that those receiving the drugs alongside the high-fat, high-cholesterol diet exhibited significantly healthier skin. These mice experienced reduced skin inflammation, fewer lesions, and much less hair loss or discoloration. Notably, they retained over 80% of their original hair, maintaining its normal black color, in stark contrast to the control group, which retained only 25% of their hair.

Future Research Directions

While the researchers are optimistic that glycosphingolipid synthesis inhibitors could benefit individuals with skin and hair disorders, further studies are necessary to assess safety and efficacy in humans. This research, despite being conducted on mice, enhances the scientific community’s understanding of skin biology and hair loss. Such foundational studies pave the way for new treatment strategies and potential therapies for hair loss and skin inflammation.

Reference

Bedja, D., Yan, W., Lad, V., Iocco, D., Sivakumar, N., Bandaru, V. V. R. & Chatterjee, S. Inhibition of glycosphingolipid synthesis reverses skin inflammation and hair loss in ApoE−/− mice fed western diet. *Scientific Reports* 8, 11463 (2018). [Link to Study](https://www.nature.com/articles/s41598-018-28663-9)